Biological characterization of a recombinant pseudorabies virus

Spanish Journal of Agricultural Research

Volumn 6, Issue 4, 2008, Pages 521-530

  Alvarez E ^a   Prieto, C ^a   Martinez Lobo F J ^a   Castro, J M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Immunization; Protection; Safety; Vaccine

Indexed keywords

SUID HERPESVIRUS 1; SUIDAE;

EID: 57649244092     PISSN: 1695971X     EISSN: None     Source Type: Journal    
DOI: 10.5424/sjar/2008064-346     Document Type: Article

References (34)

1. ARELLANO P.E., MORRISON R.B., MOLITOR T.W., THAWLEY D.G., 1992. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs. J Am Vet Med Assoc 200, 685-691.
2. BRACK A.R., KLUPP B.G., GRANZOW H., TIRABASSI R., ENQUIST L.W., METTENLEITER T.C., 2000. Role of the cytoplasmic tail of pseudorabies virus glycoprotein E in virion formation. J Virol 74, 4004-4016. doi:10.1128/JVI.74.9. 4004-4016.2000.
3. DE BRUIN M.G., DE VISSER Y.E., KIMMAN T.G., BIANCHI A.T., 1998. Time course of the porcine cellular and humoral immune responses in vivo against pseudorabies virus after inoculation and challenge: significance of in vitro antigenic restimulation. Vet Immunol Immunopathol 65, 75-87. doi:10.1016/S0165-2427(98)00175-5.
4. DONALDSON A.I., WARDLEY R.C., MARTIN S., HARKNESS J.W., 1984. Influence of vaccination on Aujeszky's disease virus and disease transmission. Vet Rec 115, 121-124.
5. FAVOREEL H.W., VAN DE WALLE G.R., NAUWYNCK H.J., METTENLEITER T.C., PENSAERT M.B., 2003. Pseudorabies virus (PRV)-specific antibodies suppress intracellular viral protein levels in PRV-infected monocytes. J Gen Virol 84, 2969-2973. doi: 10.1099/vir.0.19281-0.
6. FERNANDEZ A., MENENDEZ DEL CAMPO A.M., FERNANDEZ S., CAMACHO A., CASTRO J.M., TABARES E., 1999. Conversion of US3-encoded protein kinase gene from pseudorabies virus in a diploid gene located within inverted repeats by genetic recombination between the viral genome isomers. Virus Res 61, 125-135. doi:10.1016/S0168-1702(99)00035-0 .
7. FERRARI M., BRACK A., ROMANELLI M.G., METTENLEITER T.C., CORRADI A., DAL M.N., LOSIO M.N., SILINI R., PINONI C., PRATELLI A., 2000a. A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection. J Vet Med B Infect Dis Vet Public Health 47, 753-762. doi:10.1046/j.1439-0450.2000.00407. x.
8. FERRARI M., GUALANDI G.L., CORRADI A., MONACI C., ROMANELLI M.G., LOSIO M.N., CANTONI A.M., PRATELLI A., 2000b. The response of pigs inoculated with a thymidine kinase-negative (TK-) pseudorabies virus to challenge infection with virulent virus. Comp Immunol Microbiol Infect Dis 23, 15-26. doi:10.1016/S0147-9571(99)00019-3 .
9. FERRARI M., MARRUCHELLA G., MORE-MARSAN P., SONCINI M., BARIGAZZI G., 2000c. Properties of a thymidine kinase (TK) negative and glycoproteins I/E (gI/gE) negative mutant of pseudorabies virus. Proc. 16th International Pig Veterinary Society Congress. Melbourne, Australia, pp. 557-557.
10. FERRARI M., METTENLEITER T.C., ROMANELLI M.G., CABASSI E., CORRADI A., DAL M.N., SILINI R., 2000d. A comparative study of pseudorabies virus (PRV) strains with defects in thymidine kinase and glycoprotein genes. J Comp Pathol 123, 152-163. doi:10.1053/jcpa. 2000.0406.
11. GEENEN K., FAVOREEL H.W., OLSEN L., ENQUIST L.W., NAUWYNCK H.J., 2005. The pseudorabies virus US3 protein kinase possesses anti-apoptotic activity that protects cells from apoptosis during infection and after treatment with sorbitol or staurosporine. Virology 331, 144-150. doi:10.1016/j.virol.2004.10. 027.
12. HUSAK P.J., KUO T., ENQUIST L.W., 2000. Pseudorabies virus membrane proteins gI and gE facilitate anterograde spread of infection in projection-specific neurons in the rat. J Virol 74, 10975-10983. doi:10.1128/JVI.74.23. 10975-10983.2000.
13. KIMMAN T.G., DE WIND N., DE BRUIN T., DE VISSER Y., VOERMANS J., 1994. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity. Virology 205, 511-518. doi:10.1006/viro.1994.1672.
14. KIT S., 1990. Genetically engineered vaccines for control of Aujeszky's disease (pseudorabies). Vaccine 8, 420-424. doi:10.1016/0264-410X(90)90240-M.
15. LABARQUE G.G., NAUWYNCK H.J., MAES D.G., PENSAERT M.B., 1999. Protection of fattening pigs against challenge with Aujeszky's disease virus after a successive intranasal/intramuscular vaccination. Vet Q 21, 104-107.
16. MCFERRAN J.B., DOW C., 1975. Studies on immunisation of pigs with the Bartha strain of Aujeszky's disease virus. Res Vet Sci 19, 17-22.
17. MCGREGOR S., EASTERDAY B.C., KAPLAN A.S., BENPORAT T., 1985. Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus. Am J Vet Res 46, 1494-1497.
18. MENGELING W.L., BROCKMEIER S.L., LAGER K.M., VORWALD A.C., 1997. The role of biotechnologically engineered vaccines and diagnostics in pseudorabies (Aujeszky's disease) eradication strategies. Vet Microbiol 55, 49-60. doi:10.1016/S0378-1135(96)01306-5.
19. MULLER T.F., TEUFFERT J., ZELLMER R., CONRATHS F.J., 2001. Experimental infection of European wild boars and domestic pigs with pseudorabies viruses with differing virulence. Am J Vet Res 62, 252-258. doi:10.2460/ajvr. 2001.62.252.
20. NAUWYNCK H.J., 1997. Functional aspects of Aujeszky's disease (pseudorabies) viral proteins with relation to invasion, virulence and immunogenicity. Vet Microbiol 55, 3-11. doi:10.1016/S0378-1135(96)01299-0.
21. NAUWYNCK H.J., ZONNEKEYN V., PENSAERT M.B., 1997. Virological protection of sows upon challenge with Aujeszky's disease virus after multiple vaccinations with attenuated or inactivated vaccines. Zentralbl Veterinarmed B 44, 609-615.
22. NAUWYNCK H.J., FAVOREEL H.W., PENSAERT M., 2000. Functions of viral glycoproteins in the pathogenesis of Aujeszky's disease virus in pigs. Vet Res 31, 116-117.
23. OGG P.D., MCDONELL P.J., RYCKMAN B.J., KNUDSON C.M., ROLLER R.J., 2004. The HSV-1 Us3 protein kinase is sufficient to block apoptosis induced by overexpression of a variety of Bcl-2 family members. Virology 319, 212-224. doi:10.1016/j.virol.2003.10.019.
24. PETROVSKIS E.A., TIMMINS J.G., GIERMAN T.M., POST L.E., 1986. Deletions in vaccine strains of pseudorabies virus and their effect on synthesis of glycoprotein gp63. J Virol 60, 1166-1169.
25. QUINT W., GIELKENS A., VAN O.J., BERNS A., CUYPERS H.T., 1987. Construction and characterization of deletion mutants of pseudorabies virus: a new generation of 'live' vaccines. J Gen Virol 68, 523-534.
26. REED J.J., MUENCH T.H., 1938. A simple method to estimating fifty per cent end points. Am J Hyg 27, 493-497.
27. TIRABASSI R.S., ENQUIST L.W., 1998. Role of envelope protein gE endocytosis in the pseudorabies virus life cycle. J Virol 72, 4571-4579.
28. TIRABASSI R.S., ENQUIST L.W., 2000. Role of the pseudorabies virus gI cytoplasmic domain in neuroinvasion, virulence, and posttranslational N-linked glycosylation. J Virol 74, 3505-3516. doi:10.1128/JVI.74.8.3505-3516.2000.
29. VAN DE WALLE G.R., FAVOREEL H.W., NAUWYNCK H.J., METTENLEITER T.C., PENSAERT M.B., 2003. Transmission of pseudorabies virus from immune-masked blood monocytes to endothelial cells. J Gen Virol 84, 629-637. doi:10.1099/vir.0. 18796-0.
30. VAN ROOIJ E.M.A., HAAGMANS B.L., GLANSBEEK H.L., DE VISSER Y.E., BOERSMA W., BIANCHI A.T.J., 1999. DNA vaccine coding for glycoprotein B of PRV induces cytotoxic T cell responses in pigs against PRV. Virus Res 31, 132-133.
31. VANNIER P., 1985. Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: efficacy of attenuated live- and inactivated-virus vaccines in pigs with or without passive immunity. Am J Vet Res 46, 1498-1502.
32. VILNIS A., SUSSMAN M.D., THACKER B.J., SENN M., MAES R.K., 1998. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge. Vet Microbiol 62, 81-96. doi:10.1016/S03781135(98)00200-4.
33. YANG M., CARD J.P., TIRABASSI R.S., MISELIS R.R., ENQUIST L.W., 1999. Retrograde, transneuronal spread of pseudorabies virus in defined neuronal circuitry of the rat brain is facilitated by gE mutations that reduce virulence. J Virol 73, 4350-4359.
34. ZUFFA A., SALA J., CERNIK K., 1982. Immunity of pigs vaccinated by live or inactivated Aujeszky vaccines against experimental infection. Zentralbl Veterinarmed B 29, 663-675.